AIM ImmunoTech Inc.
AIM · AMEX
Bulios Fair Price
$0.25
33.9% upside
Trenutna cena
$0.19
Po podatkih Bulios Fair Price je delnica AIM trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
AIM ImmunoTech Inc. (AIM) is a biotechnology company focused on the research and development of immunotherapeutic drugs and treatment approaches. The company specializes in developing drugs that influence the immune system of patients to combat various diseases, including cancer and infectious diseases. AIM ImmunoTech focuses on utilizing the immune system to enhance the body's defenses and support immune responses against diseases. The company is actively engaged in scientific research and clinical trials to verify the effectiveness and safety of its drugs and approaches. Their goal is to bring new immunotherapeutic treatment options to the market that can bring improvements for patients with various diseases. AIM ImmunoTech Inc. (AIM) shares may be an attractive investment opportunity for investors interested in the biotechnology sector and seeking an investment in a company focused on innovative treatment approaches through immunotherapy.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas K. Equels
Employees
19
Headquarters
Ocala
Prihajajoči dogodki
Earnings
Upcoming earnings report